JAY DAVIS: Open Payments
NPI 1225702889 · STATE COLLEGE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,589 in 109 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $584 · 2025 $1,589
Food & beverage: $1,500Education: $89
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $490 |
| Amgen Inc. | 36 | $310 |
| GlaxoSmithKline, LLC. | 10 | $289 |
| UCB, Inc. | 12 | $154 |
| Janssen Biotech, Inc. | 2 | $108 |
| AstraZeneca Pharmaceuticals LP | 5 | $98 |
| Novartis Pharmaceuticals Corporation | 1 | $33 |
| Teva Pharmaceuticals USA, Inc. | 1 | $26 |
| Boston Scientific Corporation | 1 | $23 |
| Alvogen Inc | 1 | $22 |
Products named: RINVOQ, BENLYSTA, SKYRIZI, Bimzelx, KRYSTEXXA, TREMFYA, SAPHNELO, EVENITY.
Industry payments across PA — which companies pay providers there.
